When the correlation was made between ESR1 and IL6ST gene expression, they were positive in all breast invasive carcinoma subtypes, i.e., positive for Basal, Her2, Luminal A, and Luminal B breast cancer patients. This evidence concerns the gene ERBB2 and breast carcinoma.